CAV1 and prostate carcinoma: Specifically, we found coordinated activities through which Cav1 rewires prostate cancer cells towards exogenous scavenging of sphingomyelin, increased cancer cell catabolism of sphingomyelin to ceramide, and subsequent glycosylation to glycosphingolipid derivatives [13].